Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 114634
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.114634
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.114634
Figure 1 Synergistic role of systemic immune-inflammation index-associated immune cells in colorectal cancer progression.
NEU: Neutrophil; PLT: Platelet; LYM: Lymphocyte; NO: Nitric oxide; ROS: Reactive oxygen species; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; NETs: Neutrophil extracellular traps; VEGF: Vascular endothelial growth factor; MMP-9: Matrix metalloproteinase 9; CTCs: Circulating tumor cells; TGF-β: Transforming growth factor-β; EMT: Epithelial-mesenchymal transition; PD-L1: Programmed death-ligand 1; IFN-γ: Interferon-gamma; TME: Tumor microenvironment; MDSCs: Myeloid-derived suppressor cells; TAM: Tumor-associated macrophage; CAF: Cancer-associated fibroblasts; MMPs: Matrix metalloproteinases; SII: Systemic immune-inflammation index.
Figure 2 Clinical workflow of systemic immune-inflammation index-lactoferrin-guided perioperative management in elder colon cancer.
SII: Systemic immune-inflammation index; LF: Lactoferrin; MDT: Multidisciplinary team.
- Citation: Ren SQ, Huang ZL, Qiu ZX, Cai C. Systemic immune-inflammation index and serum lactoferrin: A novel tool for individualized prognostic assessment in elderly colon cancer. World J Gastrointest Surg 2026; 18(5): 114634
- URL: https://www.wjgnet.com/1948-9366/full/v18/i5/114634.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i5.114634